Literature DB >> 14755890

Defining the human targets of phorbol ester and diacylglycerol.

Markus Geiger1, Oliver A Wrulich, Marcel Jenny, Wolfgang Schwaiger, Hans H Grunicke, Florian Uberall.   

Abstract

Phorbol esters (PEs) and their derivatives are potent tumor-promoting agents. The best known receptors for these substances are the novel and classical isotypes of protein kinase C (PKC), which bind PE and the physiological second messenger diacylglycerol (DAG) by cysteine-rich domains, the C1 domains. However, PKC is not the sole receptor of PE, a concept that has been largely ignored in the past. PE (in addition to DAG) also targets C1-containing receptors unrelated to PKC. In order to get a better insight into DAG/PE-mediated signaling and the pathways involved, it is necessary to first determine all ligand-interacting proteins. Employing various sources of data, 66 different C1-containing human proteins are presented and predictions of their DAG/PE-binding potential are attempted. Defining the entire set of key mediators for the physiological DAG responses and for PE-induced tumorigenesis may aid our understanding of signal integration and can also help to design new strategies for therapeutic cancer intervention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14755890

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  10 in total

Review 1.  Structure-function analysis of TRPV channels.

Authors:  Barbara A Niemeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

2.  Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning.

Authors:  Daniel L Alkon; Herman Epstein; Alan Kuzirian; M Catherine Bennett; Thomas J Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

3.  WJ9708012 exerts anticancer activity through PKC-α related crosstalk of mitochondrial and endoplasmic reticulum stresses in human hormone-refractory prostate cancer cells.

Authors:  Ting-chun Kuo; Wei-jan Huang; Jih-hwa Guh
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

4.  Molecular dynamics simulation studies on binding of activator and inhibitor to Munc13-1 C1 in the presence of membrane.

Authors:  Youngki You; Joydip Das
Journal:  J Biomol Struct Dyn       Date:  2021-11-15       Impact factor: 5.235

5.  Conformationally constrained analogues of diacylglycerol. 30. An investigation of diacylglycerol-lactones containing heteroaryl groups reveals compounds with high selectivity for Ras guanyl nucleotide-releasing proteins.

Authors:  Saïd El Kazzouli; Nancy E Lewin; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2008-08-16       Impact factor: 7.446

6.  Interferon-gamma inhibits enterocyte migration by reversibly displacing connexin43 from lipid rafts.

Authors:  Cynthia L Leaphart; Shipan Dai; Steven C Gribar; Ward Richardson; John Ozolek; Xia-hua Shi; Jennifer R Bruns; Maria Branca; Jun Li; Ora A Weisz; Chhinder Sodhi; David J Hackam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-07-17       Impact factor: 4.052

7.  Diacylglycerol kinase θ: regulation and stability.

Authors:  Becky Tu-Sekine; Hana Goldschmidt; Elizabeth Petro; Daniel M Raben
Journal:  Adv Biol Regul       Date:  2012-09-20

Review 8.  Wealth of opportunity - the C1 domain as a target for drug development.

Authors:  P M Blumberg; N Kedei; N E Lewin; D Yang; G Czifra; Y Pu; M L Peach; V E Marquez
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

9.  Diacylglycerol kinase ζ controls diacylglycerol metabolism at the immunological synapse.

Authors:  Severine I Gharbi; Esther Rincón; Antonia Avila-Flores; Pedro Torres-Ayuso; María Almena; María Angeles Cobos; Juan Pablo Albar; Isabel Mérida
Journal:  Mol Biol Cell       Date:  2011-09-21       Impact factor: 4.138

10.  Sp1/3 and NF-1 mediate basal transcription of the human P2X1 gene in megakaryoblastic MEG-01 cells.

Authors:  Jiangqin Zhao; Steven J Ennion
Journal:  BMC Mol Biol       Date:  2006-03-10       Impact factor: 2.946

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.